Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-12-009905
Filing Date
2012-10-01
Accepted
2012-10-01 16:24:25
Documents
1
Period of Report
2012-09-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT rdgdoc.html 4  
1 PRIMARY DOCUMENT rdgdoc.xml 4 3496
  Complete submission text file 0001437749-12-009905.txt   4838
Mailing Address 81 FULTON STREET BOONTON NJ 07005
Business Address 81 FULTON STREET BOONTON NJ 07005 973-265-1100
UNIGENE LABORATORIES INC (Issuer) CIK: 0000352747 (see all company filings)

EIN.: 222328609 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address C/O UNIGENE LABORATORIES, INC. 81 FULTON ST. BOORTON NJ 07005
Business Address
Tune Joel A. (Reporting) CIK: 0001501799 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16005 | Film No.: 121120219